Morgan Stanley Raises Price Target for Align Technology to $169

Morgan Stanley raises price target for Align Technology (ALGN) to $169, a 9.74% increase, and maintains an Equal-Weight rating. This adjustment reflects a positive outlook for the company and its leading clear aligner product Invisalign, which dominates over 90% of the market. Analysts forecast an average target price of $183.41, indicating an upside of 13.71% from the current price. The estimated GF Value for ALGN in one year is $264.21, suggesting a potential upside of 63.8% from the current price.